Search results
Frances Kathleen Oldham Kelsey CM ( née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American [1] pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. [2] .
- 2
- August 7, 2015 (aged 101), London, Ontario, Canada
- Frances Kathleen Oldham, July 24, 1914, Cobble Hill, British Columbia, Canada
- Preventing thalidomide from being marketed in the United States
Frances Oldham Kelsey, recipient of the highest recognition attainable for a U. S. civil servant for her role in saving perhaps thousands from death or life-long incapacitation, had a long an...
Learn about the life and achievements of Dr. Frances Kelsey, a pharmacologist who refused to approve thalidomide in the US in 1962, saving thousands of lives and earning the President's Award for Distinguished Federal Civilian Service. Find out how she shaped and enforced FDA drug regulation laws to protect the health of the American people.
1914-2015. By Miriam Erick, MS RDN. Frances “Frankie” Kathleen Oldham Kelsey. Kelsey was universally credited with sparing the US the damage inflicted by the drug thalidomide to the human nervous system by refusing to approve the drug for distribution in the US.
Aug 7, 2015 · Health & Science. Frances Oldham Kelsey, FDA scientist who kept thalidomide off U.S. market, dies at 101. By Adam Bernstein. and. Patricia Sullivan. August 7, 2015 at 12:53 p.m. EDT. Dr....
People also ask
Who is Frances Oldham Kelsey?
Why did Frances Oldham Kelsey refuse thalidomide?
Who is Frances Kelsey?
Who was Frances Oldham?
Aug 7, 2015 · President John F. Kennedy gave Dr. Frances Oldham Kelsey the nation’s highest federal civilian service award in 1962, saying she had “prevented a major tragedy of birth deformities.” The...
Biography. In 1960, during her first month at the Food and Drug Administration, Dr. Frances Oldham Kelsey took a bold stance against inadequate testing and corporate pressure when she refused to approve release of thalidomide in the United States.
